More recently, we have uncovered obesity-driven cancers in our mouse models with disruption of TGF-β signaling and loss of aldehyde dehydrogenase 2 (Aldh2) (24, 25). The gene discussed is TGFB1; the disease is obesity due to melanocortin 4 receptor deficiency.